About Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome is a rare disease catalogued by Orphanet (ORPHA:415). It is associated with the SLC25A15 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome trials.
Search ClinicalTrials.gov for "Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome" or filter by Orphanet code ORPHA:415 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Updated daily.